Dr. Hari K Koul,
Associate Director
, LSU Health Sciences Center , USA
,LSU Health Sciences Center, USA
Biography
Dr. Hari K. Koul is Professor LSUHSC-School of Medicine, Departments of Interdisciplinary Oncology, Biochemistry and Molecular Biology and Urology. He concurrently serves as Associate Director for the Stanley S Scott Cancer Center/Head of the GU Oncology Research Program at LSUHSC and Research Physiologist at the New Orleans VA Medical Center. He is internationally recognized as one of the leading translational researchers in urologic diseases. Over the past three decades, Dr. Koul has greatly contributed to our understanding of molecular mechanisms, specifically signal transduction pathways in genitor-urinary disorders. Dr. Koul’s research is focused on understanding the mechanisms of tumor progression and the emergence of therapeutic resistance, with special focus on epigenetic mechanisms and spatio-temporal regulation of gene expression; identification of novel markers that could potentially distinguish indolent vs. aggressive prostate cancer; developing new small molecular inhibitors to overcome therapy resistance, and evaluation of the role of Prostate Derived Ets Transcription Factor in PCa Health Disparities.
Research Interest
Tumor progression and the emergence of therapeutic resistance